AI Article Synopsis

  • Preclinical studies indicate that stress before pregnancy can lead to lasting changes in behavior and mental health in offspring.
  • Venlafaxine, a common antidepressant, has not been thoroughly studied for safety during pregnancy and breastfeeding, prompting this investigation into its effects on stressed mother rats and their female pups.
  • Findings suggest that maternal stress reduces pup numbers and leads to anxiety-like behavior in offspring, but venlafaxine treatment appears to normalize anxiety levels in adult females, highlighting the need for more clarity on the best antidepressant options for treating maternal depression.

Article Abstract

Preclinical studies suggest that stress-related disorders even prior gestation can cause long-term changes at the level of neurobehavioral adaptations. Therefore, it is critical to consider undergoing antidepressant therapy which could reverse the negative consequences in the offspring. Venlafaxine is widely used in clinical practice; however insufficient amount of well-controlled studies verified the safety of venlafaxine therapy during gestation and lactation. The aim of this work was to investigate the effects of perinatal venlafaxine therapy on selected neurobehavioral variables in mothers and their female offspring using a model of maternal adversity. Pre-gestational stressed and non-stressed Wistar rat dams were treated with either venlafaxine (10 mg/kg/day) or vehicle during pregnancy and lactation. We have shown that pre-gestational stress decreased the number of pups with a significant reduction in the number of males but not females. Furthermore, we found that offspring of stressed and treated mothers exhibited anxiogenic behavior in juvenile and adolescent age. However, during adulthood pre-gestational stress significantly increased anxiety-like behavior of female, with venlafaxine treatment normalizing the state to control levels. Additionally, we found that even maternal stress prior gestation can have long-term impact on adult number of hippocampal immature neurons of the female offspring. A number of questions related to the best treatment options for maternal depression still remains, however present data may provide greater insight into the possible outcomes associated with perinatal venlafaxine therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbr.2020.112944DOI Listing

Publication Analysis

Top Keywords

pre-gestational stress
12
perinatal venlafaxine
12
female offspring
12
venlafaxine therapy
12
venlafaxine treatment
8
prior gestation
8
gestation long-term
8
venlafaxine
7
offspring
5
long-term effects
4

Similar Publications

Article Synopsis
  • The COVID-19 pandemic significantly impacted healthcare delivery for pregnant adolescents, affecting their maternal and neonatal outcomes due to challenges like isolation and restricted access to care.
  • A study of 340 adolescent patients revealed that during the pandemic, cesarean delivery rates and cervicovaginitis caused by Ureaplasma spp. increased, while pre-pandemic patients exhibited higher rates of substance use and urinary tract infections.
  • Overall, the findings indicate that healthcare system changes during the pandemic led to differing health outcomes, emphasizing the need for focused care for this vulnerable group during public health crises.
View Article and Find Full Text PDF

Exposure by women to stressors before pregnancy increases their risk of contracting prenatal depression, a condition which typically may require antidepressant treatment. And even though such perinatal antidepressant treatment is generally considered to be safe. For the mother, its effects on the development and functioning of the offspring`s brain remain unknown.

View Article and Find Full Text PDF

We aimed to determine, using in vivo magnetic resonance, whether maternal depression induced by chronic unpredictable stress (CUS) in the pre-gestational period in female rats would be evidenced by structural or neurometabolic changes in the hippocampal region of the brain. At the same time, appropriate behavioral tests were also administered after a relatively long two-month period of a stress paradigm. The objective of the study was not only to study an animal model of CUS using magnetic resonance imaging (MRI) and proton magnetic resonance spectroscopy (H MRS) focused on the hippocampus, but also to use this technique to verify the effectiveness of mirtazapine antidepressant treatment.

View Article and Find Full Text PDF

Major Depressive Disorder (MDD) with Peripartum Onset was classified in 2013 by the Diagnostic and Statistical Manual, Fifth Edition (DMS-5) and approved in 2019 by the World Health Organization (WHO). These diagnostic revisions call for the development of new animal models of maternal depression, emphasizing the pregnancy period. We have recently described a novel rat model of maternal MDD with a Peripartum Onset.

View Article and Find Full Text PDF

Hormonal fluctuations, such as the perinatal period, may increase susceptibility of women to depression, which in turn exert a negative impact on child's neurodevelopment, becoming a risk factor in development of neuropsychiatric disorders. Moreover, the use of antidepressants during this critical period presents a serious health concern for both the mother and the child, due to the consequences of treatment in terms of the reliability and safety for the proper neurodevelopment of the organism being not well known. Atypical antidepressants, such as mirtazapine, that targets both serotonergic and noradrenergic systems in the central nervous system (CNS), represent a novel focus of research due to its unique pharmacological profile.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!